4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-19-031009
Options or other derivatives
- Director acquired 6,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| DRISCOLL FREDERICK W Director | 2019-06-13 | Grant or award · Stock option (right to buy) | +6,500 | 6,500 | D | ||
Loading xslF345X03/tv523610_4.xml…